10 ENGLISH BOOKS RELATING TO «CYSTEAMINE»
Discover the use of
cysteamine in the following bibliographical selection. Books relating to
cysteamine and brief extracts from same to provide context of its use in English literature.
INTRODUCTION During the 1960s, Cavallini and coworkers demonstrated the
presence of a protein with cysteamine dioxygenase activity in animal tissues and
proposed that this enzyme was important in the conversion of cysteamine to ...
Simo S. Oja, Pirjo Saransaari, 2006
2
Mercaptoethylamines—Advances in Research and Application: ...
Patent. Application. Titled. “Enterically. Coated. Cysteamine,. Cystamine. and.
Derivatives. Thereof”. Under. Review. By a News Reporter-Staff News Editor at
Biotech Week — According to news reporting originating from Washington, DC, ...
3
Pathophysiology of Lysosomal Transport
cystine + cysteamine (mw-240) (mw-77) -*- mixed disulfide + cysteine- (mw-196)
(mw-120) mixed disulfide + cysteamine ▻- cystaminen ♢ cysteine / (mw-152) \ / \
I I ' LYSOSOMAL SPACE \ * 7 \ / M i N CYSTEAMINE -« CYSTAMINE^ i ...
4
Molecular and Genetic Basis of Renal Disease
Normal lysosome Cystine Lysine Untreated cystinotic lysosome Cystine Lysine
Lysine Cysteamine-treated cystinotic lysosome Cysteamine Mixed disulfide of
cysteine and cysteamine Cysteine Figure 14-8 The mechanism of cystine
depletion ...
David B. Mount, Martin R. Pollak, 2008
5
Ulcer Disease: New Aspects of Pathogenesis and Pharmacology
contribution of the gastric acid hypersecretion to the depletion of the PPPase
activity after administration of cysteamine was examined by pretreatment of rats
with the histamine H2- receptor antagonist, cimetidine, and by pylorus ligation.
Sandor Szabo, Carl J. Pfeiffer, 1989
6
Virus Diseases: New Insights for the Healthcare ...
“In a related embodiment, a cysteamine compound is administered alone or
concurrently with other known agents that are used to treat and/or prevent an
avian influenza viral (AIV) infection. According to the present invention, the
cysteamine ...
7
Physician's Guide to the Treatment and Follow-up of ...
Cysteamine has been proven to preserve the kidneys from further glomerular
damage. Cysteamine should be administered orally as cysteamine bitartrate (
Cystagon). In contrast to cysteamine, HC1 cysteamine bitartrate is not
hygroscopic.
Nenad Blau, Georg F. Hoffmann, James Leonard, 2006
8
Class 3 Hydrolases: EC 3.4.22-3.13
Pantetheinase activity of vanin-1 is a major regulator of intestinal inflammation,
acting through cysteamine release [11]) (Reversibility: ?) [5, 6, 7, 8, 10, 11, 15] P
? Substrates and products S (R)-pantetheine + H2O <2, 3> (Reversibility: ?) ...
Dietmar Schomburg, Antje Chang, Ida Schomburg, 2009
9
Endogenous Mediators of Gastrointestinal Damage
Animal model: cysteamine-induced acute and chronic duodenal ulcer in the rat.
Am. J. Pathol.. 93. 273. 1978. 12. Takeuchi, K., Furukawa, O., Nishiwaki, H., and
Okabe, S., 16, 16-Dimethyl prostaglandin E2 aggravates gastric mucosal injury ...
10
Handbook of Bioequivalence Testing
A study of the relative bioavailability of cysteamine hydrochloride, cysteamine
bitartrate and phosphocysteamine in healthy adult male volunteers Tenneze L,
Daurat V, Tibi A, Chaumet-Riffaud P, Funck-Brentano C. Br J Clin Pharmacol
1999 ...
10 NEWS ITEMS WHICH INCLUDE THE TERM «CYSTEAMINE»
Find out what the national and international press are talking about and how the term
cysteamine is used in the context of the following news items.
Raptor Pharmaceutical Corp. Downgraded by Oppenheimer (RPTP)
In Europe, PROCYSBI gastro-resistant hard capsules of cysteamine, received a marketing authorization from the EC, as an orphan medicinal ... «The Legacy, Jul 15»
Raptor Pharmaceutical Corp. Lowered to "Underperform" at …
In Europe, PROCYSBI gastro-resistant hard capsules of cysteamine, received a marketing authorization from the EC, as an orphan medicinal product for the ... «Dakota Financial News, Jul 15»
The NASH drug dash
... fatty-acid–bile-acid conjugate that boosts liver fat metabolism; Raptor's Phase II delayed-release cysteamine bitartrate is a cysteine-depleting ... «Nature.com, Jul 15»
Thomas Daley Unloaded 35000 Shares of Raptor Pharmaceutical …
In Europe, PROCYSBI gastro-resistant hard capsules of cysteamine, received a marketing authorization from the EC, as an orphan medicinal ... «OctaFinance.com, Jun 15»
Drug brings new hope for cystic fibrosis victims
The active component of the new medicine is Cysteamine, a drug used for 20 years to treat an unrelated rare condition called cystinosis, which ... «Scotsman, Jun 15»
New drug 'could ease symptoms of cystic fibrosis'
The active component of the new medicine is Cysteamine, a drug used for 20 years to treat an unrelated rare condition called cystinosis. «BBC News, Jun 15»
Raptor Pharmaceutical Corp. 46.5% Potential Upside Indicated by …
The Company's product, PROCYSBI (cysteamine bitartrate) delayed-release capsules, received approval from the United States Food and ... «DirectorsTalk Interviews, Jun 15»
Raptor Pharmaceutical to Participate in Upcoming Investor …
Raptor holds intellectual property for the use of cysteamine in HD and other neurodegenerative disorders including Parkinson's disease and ... «Stockhouse, May 15»
Thomas Daley Sold 10000 Shares of Raptor Pharmaceutical Corp …
The Company's product, PROCYSBI (cysteamine bitartrate) delayed-release capsules, received approval from the United States Food and ... «OctaFinance.com, May 15»
Biotech Stocks For Your Portfolio - Raptor Pharmaceutical (NASDAQ …
Global net product sales for PROCYSBI(R) (cysteamine bitartrate) delayed-release capsules were $20.5 million for the first quarter ended ... «Wall Street Observer, May 15»
